Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DS17701585 is an orally active, selective inhibitor of EP300 and CBP, capable of acting on CBP (IC50: 0.040 μM), EP300 (IC50: 0.15 μM), H3K27 (IC50: 0.45 μM) and SOX2 (IC50: 0.7 μM), and can be used to study cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | DS17701585 is an orally active, selective inhibitor of EP300 and CBP, capable of acting on CBP (IC50: 0.040 μM), EP300 (IC50: 0.15 μM), H3K27 (IC50: 0.45 μM) and SOX2 (IC50: 0.7 μM), and can be used to study cancer. |
Molecular Weight | 482.55 |
Formula | C24H26N4O5S |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.